Overview

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.
Phase:
Phase 2
Details
Lead Sponsor:
Nitric BioTherapeutics, Inc
Treatments:
Methicillin
Nitric Oxide